UK regulatory approval for SCIB1 phase II advanced melanoma trial
The study is designed to assess whether the addition of SCIB1 treatment will result in an improvement in the tumour response rate.
Read More
Tag: Phase II trial
Verona announces positive results from Phase II COPD trial
Verona Pharma’s COPD inhaler has shown positive results in a Phase II study.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
